Management
Howard J. Jacob, Ph. D., Chief Executive Officer
Dr. Jacob directs the genetic and genomic science at PhysioGenix through the directors of research. Dr. Jacob is Director of the Human and Molecular Genetics Center at the Medical College of Wisconsin. He is known for applying genomics, and high through-put phenotyping, as well as comparative genomics and bioinformatics. His research centers on physiological genetics, genetic dissection and analysis of complex disease, especially target organ damage associated with diabetes mellitus and hypertension. He is the leading authority on quantitative molecular genetics of complex disease and Functional Genomics with over 100 published research articles.
Read Dr. Jacobs's Publications at PubMed
Brian D. Curry, Ph. D., Chief Operating Officer
Dr. Curry is responsible for managing day-to-day activities and identifying innovative solutions to bring products to market. Dr. Curry has a proven track record of strategic planning and commercialization. Prior to coming to PhysioGenix, Dr. Curry was President of Functional Design for 10 years, which provided biomechanical design, testing and consulting to National and global companies. During this time, he brought products from concept sketches through manufacturing and product launch. Dr. Curry has written and orchestrated the submission of over $32 M of federal grants from 7 different agencies, resulting in multiple peer-reviewed articles and international speeches. He holds a Ph.D. in Cell Biology, Neurobiology and Anatomy and an M.S. in Pharmacology & Toxicology from the Medical College of Wisconsin, M.S. in Biological Sciences/Physiology from Western Michigan University and a B.S. in Physics from Michigan State University.
Richard J. Roman, Ph. D., Chief Scientific Officer
Chief Scientific Officer Dr. Roman manages the scientific programs for all of the in vivo work at PhysioGenix. He is also responsible for generating research proposals for all renal related research associated with T2DN and meets with the technical teams regularly. Dr. Roman is the Director of the Renal Center at the Medical College of Wisconsin and a leading expert in cardiovascular and renal physiology and pharmacology. He has experience with an array of techniques including micropuncture, tubular perfusion, intracellular imaging, immunohistochemistry, molecular biology, laser Doppler flowmetry, mass spectroscopy and long term studies in animal models. At MCW, he specializes on in vivo animal models, kidney disease, diabetic nephropathy, and hypertension. His expertise ranges from whole animal physiology and clinical assay development to molecular biology with over 245 research articles.
Read Dr.Roman's Publications at PubMed
Annette Dahly-Vernon, Ph. D., Senior Study Director and Client Development
Dr. Dahly-Vernon directs research projects at PhysioGenix focused on in vivo animal models in cardiovascular and renal area specifically in hypertension and diabetic nephropathy. Dr. Dahly-Vernon was awarded the prestigious Goldblatt Award from the American Heart Association in 2005. She completed her Ph.D. work in physiology at the Medical College of Wisconsin.
Steven H. Nye, Ph. D., Director of Research Programs
Dr. Nye leads the genomics research effort at PhysioGenix with specialties in cellular and molecular biology. During the past five years, Dr. Nye has been awarded $5 million in grants as Principal Investigator for PhysioGenix's SBIR grants in the areas of diabetes, toxicogenomics, biodefense, alcoholism and genetic models for drug target identification. Dr. Nye has helped to discover new models for use in PhysioGenix's animal models. Prior to joining PhysioGenix, Dr. Nye was employed by several start-up biotechnology companies and was also an Assistant Professor at the Medical College of Wisconsin. Dr. Nye's research work has been published in peer-reviewed journals and he is an inventor on numerous patents. Dr. Nye completed his doctoral training at Northwestern University.
Darin L. Evans, M.S. Brand Manager and Business Development
Mr. Evans manages sales and marketing activities. As manager of the Chemistry Core Lab, he has furthered the development of clinical and cell based assays along with cDNA microarray technology at PhysioGenix, Inc. Mr. Evans received his Masters of Science degree in Chemistry and his Bachelor of Science degrees in Microbiology and Biochemistry from the University of Wisconsin-Milwaukee.